missing translation for 'onlineSavingsMsg'
Learn More

CERILLIANT™ Clorazepate dipotassium Solution, 1.0 mg/mL in Methanol (as clorazepate), Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  Merck Emd Millipore C1561ML

Catalog No. 01001112


Only null left
Explore available promotions

Description

Description

A certified analytical reference solution suitable for use in benzodiazepine testing methods by GC/MS or LC/MS for applications in clinical toxicology, urine drug testing or forensic analysis. Clorazepate dipotassium is a long-acting benzodiazepine with anxiolytic, anticonvulsant, sedative and hypnotic properties. Clorazepate dipotassium, marketed under the brand name Tranxene™, is a prodrug for nordiazepam, which is produced as an active metabolite.
Specifications

Specifications

67-56-1,57109-90-7
UN 1230 - class 3 - PG 2 - Methanol, solution
408.92
1 mL
C16H11ClK2N2O4
1.0 mg/mL in methanol (as clorazepate)
Ampule
9.7°C (49.5°F) - closed cup
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Promotions

Promotions

CERILLIANT is a registered trademark of Cerilliant Corporation